Artemisinin resistance on the Thai-Cambodian border

The Lancet

Volumn 374, Issue 9699, 2009, Pages 1419-

  Müller, Olaf ^a   Sié, Ali ^b   Meissner, Peter ^a   Schirmer, R Heiner ^a   Kouyaté, Bocar ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b CENTRE DE RECHERCHE EN SANTÉ DE NOUNA   (Burkina Faso)

^c Burkina Faso   (Burkina Faso)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; AMODIAQUINE PLUS ARTESUNATE; ARTEMISININ; ARTEMISININ DERIVATIVE; ARTESUNATE; METHYLENE BLUE;

ANTIMALARIAL DRUG RESISTANCE; CAMBODIA; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; GAMETOCYTE; HUMAN; LETTER; MALARIA; MALARIA FALCIPARUM; MONOTHERAPY; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

EID: 70350244603     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61857-2     Document Type: Letter

References (5)

1. Samarasekera U. Countries race to contain resistance to key antimalarial. Lancet 374 (2009) 277-280
2. Kouyaté B., Sié A., Ye M., De Allegri M., and Müller O. The great failure of malaria control in Africa: a district perspective from Burkina Faso. PLoS Med 4 (2007) e127
3. Baird J.K. Effectiveness of antimalarial drugs. N Engl J Med 352 (2005) 1565-1577
4. Zoungrana A., Coulibaly B., Sié A., et al. Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. PLoS ONE 3 (2008) e1630
5. Coulibaly B., Zoungrana A., Mockenhaupt F., et al. Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial. PLoS ONE 4 (2009) e5318